US Stock MarketDetailed Quotes

AMPED AMPIO PHARMACEUTICALS INC

Watchlist
  • 0.510
  • 0.0000.00%
15min DelayClose Nov 21 16:00 ET
7.69MMarket Cap-264P/E (TTM)

AMPIO PHARMACEUTICALS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-51.99%-5.94M
-155.46%-5.95M
-19.22%-4.94M
4.35%-14.09M
-28.61%-3.7M
-44.49%-3.91M
49.28%-2.33M
8.92%-4.15M
4.25%-14.73M
39.38%-2.88M
Net income from continuing operations
-76.66%-6.41M
41.77%-2.07M
-53.70%-5.64M
-7.43%-17.08M
-34.81%-6.22M
-7.78%-3.63M
-30.17%-3.56M
29.19%-3.67M
-16.61%-15.89M
-352.65%-4.62M
Operating gains losses
-425.68%-1.17M
-2,387.93%-2.89M
-781.46%-1.33M
-4,950.00%-3.49M
-525.35%-3M
-436.36%-222K
-188.55%-116K
81.83%-151K
101.48%72K
111.57%706K
Depreciation and amortization
31.94%347K
-6.57%256K
-10.88%262K
-7.05%1.09M
-9.93%263K
-10.54%263K
-7.43%274K
-0.34%294K
-7.47%1.18M
-1.68%292K
Other non cash items
----
----
----
-87.18%80K
--0
--0
--0
0.00%80K
680.00%624K
--0
Change In working capital
-119.78%-811K
-215.87%-1.16M
220.25%1.05M
229.97%2.58M
1,203.70%2.82M
-109.66%-369K
134.62%1M
-200.00%-869K
-246.06%-1.99M
-89.18%216K
-Change in prepaid assets
-25.00%381K
-22.32%-685K
202.92%670K
-203.85%-593K
-66.46%110K
7.63%508K
39.59%-560K
-193.27%-651K
144.93%571K
175.63%328K
-Change in payables and accrued expense
-36.69%-1.17M
-128.39%-450K
299.50%397K
231.80%3.26M
3,132.22%2.73M
-36.04%-853K
181.41%1.59M
-205.29%-199K
-191.67%-2.48M
-104.75%-90K
-Change in other current liabilities
-8.33%-26K
-13.04%-26K
-15.79%-22K
-9.88%-89K
-4.55%-23K
-14.29%-24K
-15.00%-23K
-5.56%-19K
-15.71%-81K
-22.22%-22K
Cash from discontinued investing activities
Operating cash flow
-51.99%-5.94M
-155.46%-5.95M
-19.22%-4.94M
4.35%-14.09M
-28.61%-3.7M
-44.49%-3.91M
49.28%-2.33M
8.92%-4.15M
4.25%-14.73M
39.38%-2.88M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-53.97%-97K
0
66.67%-16K
0
-81K
-186.36%-63K
-87.50%-15K
Net PPE purchase and sale
--0
--0
--0
-53.97%-97K
--0
66.67%-16K
--0
---81K
-186.36%-63K
-87.50%-15K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
-53.97%-97K
--0
66.67%-16K
--0
---81K
-186.36%-63K
-87.50%-15K
Financing cash flow
Cash flow from continuing financing activities
0
0
-104.13%-111K
20.02%30.73M
88.22%20.48M
-93.19%495K
0.80%7.07M
516.06%2.69M
78.41%25.61M
235.08%10.88M
Net common stock issuance
--0
--0
-102.80%-79K
25.33%32.83M
99.73%22.08M
-92.52%540K
2.16%7.39M
313.34%2.82M
115.71%26.19M
--11.06M
Proceeds from stock option exercised by employees
----
----
----
-70.11%234K
----
----
----
----
-79.79%783K
-90.92%320K
Net other financing activities
--0
--0
75.94%-32K
-70.18%-2.33M
-270.91%-1.84M
85.62%-45K
0.00%-314K
45.93%-133K
17.79%-1.37M
-78.70%-495K
Cash from discontinued financing activities
Financing cash flow
--0
--0
-104.13%-111K
20.02%30.73M
88.22%20.48M
-93.19%495K
0.80%7.07M
516.06%2.69M
78.41%25.61M
235.08%10.88M
Net cash flow
Beginning cash position
11.39%22.89M
82.47%28.84M
95.39%33.89M
165.55%17.35M
82.87%17.12M
324.39%20.55M
554.41%15.8M
165.55%17.35M
-13.88%6.53M
16.37%9.36M
Current changes in cash
-73.21%-5.94M
-225.33%-5.95M
-227.82%-5.06M
53.01%16.55M
110.07%16.77M
-175.92%-3.43M
95.51%4.75M
62.55%-1.54M
1,126.97%10.81M
628.11%7.99M
End cash Position
-1.00%16.95M
11.39%22.89M
82.47%28.84M
95.39%33.89M
95.39%33.89M
82.87%17.12M
324.39%20.55M
554.41%15.8M
165.55%17.35M
165.55%17.35M
Free cash flow
-51.38%-5.94M
-155.46%-5.95M
-16.93%-4.94M
4.10%-14.19M
-27.94%-3.7M
-42.56%-3.93M
49.28%-2.33M
7.14%-4.23M
3.98%-14.79M
39.17%-2.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -51.99%-5.94M-155.46%-5.95M-19.22%-4.94M4.35%-14.09M-28.61%-3.7M-44.49%-3.91M49.28%-2.33M8.92%-4.15M4.25%-14.73M39.38%-2.88M
Net income from continuing operations -76.66%-6.41M41.77%-2.07M-53.70%-5.64M-7.43%-17.08M-34.81%-6.22M-7.78%-3.63M-30.17%-3.56M29.19%-3.67M-16.61%-15.89M-352.65%-4.62M
Operating gains losses -425.68%-1.17M-2,387.93%-2.89M-781.46%-1.33M-4,950.00%-3.49M-525.35%-3M-436.36%-222K-188.55%-116K81.83%-151K101.48%72K111.57%706K
Depreciation and amortization 31.94%347K-6.57%256K-10.88%262K-7.05%1.09M-9.93%263K-10.54%263K-7.43%274K-0.34%294K-7.47%1.18M-1.68%292K
Other non cash items -------------87.18%80K--0--0--00.00%80K680.00%624K--0
Change In working capital -119.78%-811K-215.87%-1.16M220.25%1.05M229.97%2.58M1,203.70%2.82M-109.66%-369K134.62%1M-200.00%-869K-246.06%-1.99M-89.18%216K
-Change in prepaid assets -25.00%381K-22.32%-685K202.92%670K-203.85%-593K-66.46%110K7.63%508K39.59%-560K-193.27%-651K144.93%571K175.63%328K
-Change in payables and accrued expense -36.69%-1.17M-128.39%-450K299.50%397K231.80%3.26M3,132.22%2.73M-36.04%-853K181.41%1.59M-205.29%-199K-191.67%-2.48M-104.75%-90K
-Change in other current liabilities -8.33%-26K-13.04%-26K-15.79%-22K-9.88%-89K-4.55%-23K-14.29%-24K-15.00%-23K-5.56%-19K-15.71%-81K-22.22%-22K
Cash from discontinued investing activities
Operating cash flow -51.99%-5.94M-155.46%-5.95M-19.22%-4.94M4.35%-14.09M-28.61%-3.7M-44.49%-3.91M49.28%-2.33M8.92%-4.15M4.25%-14.73M39.38%-2.88M
Investing cash flow
Cash flow from continuing investing activities 000-53.97%-97K066.67%-16K0-81K-186.36%-63K-87.50%-15K
Net PPE purchase and sale --0--0--0-53.97%-97K--066.67%-16K--0---81K-186.36%-63K-87.50%-15K
Cash from discontinued investing activities
Investing cash flow --0--0--0-53.97%-97K--066.67%-16K--0---81K-186.36%-63K-87.50%-15K
Financing cash flow
Cash flow from continuing financing activities 00-104.13%-111K20.02%30.73M88.22%20.48M-93.19%495K0.80%7.07M516.06%2.69M78.41%25.61M235.08%10.88M
Net common stock issuance --0--0-102.80%-79K25.33%32.83M99.73%22.08M-92.52%540K2.16%7.39M313.34%2.82M115.71%26.19M--11.06M
Proceeds from stock option exercised by employees -------------70.11%234K-----------------79.79%783K-90.92%320K
Net other financing activities --0--075.94%-32K-70.18%-2.33M-270.91%-1.84M85.62%-45K0.00%-314K45.93%-133K17.79%-1.37M-78.70%-495K
Cash from discontinued financing activities
Financing cash flow --0--0-104.13%-111K20.02%30.73M88.22%20.48M-93.19%495K0.80%7.07M516.06%2.69M78.41%25.61M235.08%10.88M
Net cash flow
Beginning cash position 11.39%22.89M82.47%28.84M95.39%33.89M165.55%17.35M82.87%17.12M324.39%20.55M554.41%15.8M165.55%17.35M-13.88%6.53M16.37%9.36M
Current changes in cash -73.21%-5.94M-225.33%-5.95M-227.82%-5.06M53.01%16.55M110.07%16.77M-175.92%-3.43M95.51%4.75M62.55%-1.54M1,126.97%10.81M628.11%7.99M
End cash Position -1.00%16.95M11.39%22.89M82.47%28.84M95.39%33.89M95.39%33.89M82.87%17.12M324.39%20.55M554.41%15.8M165.55%17.35M165.55%17.35M
Free cash flow -51.38%-5.94M-155.46%-5.95M-16.93%-4.94M4.10%-14.19M-27.94%-3.7M-42.56%-3.93M49.28%-2.33M7.14%-4.23M3.98%-14.79M39.17%-2.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data